18-Jun-2024
No headlines found.
Business Wire (Tue, 4-Jun 8:30 AM ET)
Globe Newswire (Wed, 29-May 9:00 AM ET)
HCA Healthcare, Inc. to Present at June Healthcare Conference
Business Wire (Fri, 10-May 4:31 PM ET)
AREX Capital Expresses Disappointment in Enhabit's Strategic Review Conclusion
Globe Newswire (Thu, 9-May 9:15 AM ET)
MATTERWORKS ANNOUNCES UPDATES TO LEADERSHIP TEAM
PRNewswire (Thu, 2-May 10:02 AM ET)
HCA Healthcare Reports First Quarter 2024 Results
Business Wire (Fri, 26-Apr 7:30 AM ET)
Globe Newswire (Wed, 24-Apr 7:00 AM ET)
Business Wire (Tue, 23-Apr 9:30 AM ET)
Fortune Names HCA Healthcare One of the World's Most Admired Companies
Business Wire (Mon, 22-Apr 8:30 AM ET)
Business Wire (Fri, 19-Apr 9:30 AM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of June 18, 2024, HCA stock price climbed to $340.64 with 695,625 million shares trading.
HCA has a beta of 0.92, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.24 to the broad based SPY ETF.
HCA has a market cap of $89.22 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $17 billion in Revenue and $5.36 earnings per share. This beat revenue expectation by $559 million and exceeded earnings estimates by $.35.
In the last 3 years, HCA stock traded as high as $343.53 and as low as $164.47.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
HCA has underperformed the market in the last year with a price return of +18.3% while the SPY ETF gained +26.0%. HCA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +6.0% and +2.6%, respectively, while the SPY returned +7.6% and +3.9%, respectively.
HCA support price is $330.52 and resistance is $340.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA stock will trade within this expected range on the day.